#CPhIChat Returns to CPhI Worldwide for the Second Successive Year
News Oct 10, 2015
CPhI Worldwide, (#cphiww) organized by UBM EMEA, has announced the second annual #CPhIChat, an industry-wide Tweetchat for pharma professionals and media working across the supply chain, aimed to stimulate conversations on key industry issues and facilitate shared knowledge building.
Taking place on Wednesday 14th October, from 2 to 4pm, the #CPhIChat will focus on the industry insights and forecasts delivered by CPhI’s expert panel in this year’s Annual Report. Now in it’s third successive year, the 2015 report features a collection of in-depth articles from 12 expert panel members who have given focus on a number of key issues currently surrounding pharma and projections for the future.
For 2015, the highlights and key predictions and trends affecting the industry include:
• Patent laws and regulatory changes
• QbD and continuous processing
• Biologics and steriles growth
CPhI will open the Tweetchat conversation by presenting key facts (with infographics) live at the show. This interactive initiative will link the media, some 36,000 people in attendance – via screens live at the show – and the wider global industry, who will be asked to weight-in on the discussion.
“Introducing #CPhIChat to the Worldwide event was a huge success last year and we are delighted to bring it back once more for further thought-provoking discussion on key issues surrounding the pharmaceutical industry. This platform is a great outlet for driving innovation and thought leadership alongside the exhibition, conferences and showcases.”Chris Kilbee, Group Director Pharma at CPhI.
CPhI encourages the entire industry to log into Twitter from 2 to 4 pm on Wednesday 14th October to join the debate by using the hashtags #CPhIChat and #CPhIWW. CPhI Worldwide attendees can follow the debate in real-time on the display screens that will be set-up throughout the exhibition. Alternatively, the debate can be followed by searching for the hashtags on Twitter from anywhere in the world. A summary report will be released after the show.
PhoreMost and Plexxikon Collaborate to Identify Novel Drug TargetsNews
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, today announced it has signed a collaborative agreement with Plexxikon Inc., the small molecule structure-guided R&D centre of Daiichi Sankyo.READ MORE
Lonza Opens World’s Largest Dedicated Cell-and-Gene-Therapy Manufacturing Facility in TexasNews
First-of-its-kind, state-of-the-art manufacturing facility with capacity to produce treatment for thousands of patients suffering from rare genetic disorders or life-threatening diseases.READ MORE
IONTAS and IGEM Therapeutics Collaborate to Identify Novel IgE AntibodiesNews
The project will add to IGEM’s pipeline of drugs and expand upon IGEM-F, an IgE targeting ovarian and other cancers, currently in a Phase 1/2a study.READ MORE
Comments | 0 ADD COMMENT
World Congress on Advanced Biomaterials and Tissue Engineering
Jun 20 - Jun 21, 2018